首页> 外文期刊>Journal of drug delivery science and technology >Polyelectrolyte complexes of carboxymethyl chitosan/alginate based drug carrier for targeted and controlled release of dual drug
【24h】

Polyelectrolyte complexes of carboxymethyl chitosan/alginate based drug carrier for targeted and controlled release of dual drug

机译:羧甲基壳聚糖/藻酸盐基于双药的靶向和控释释放的聚电解质复合物

获取原文
获取原文并翻译 | 示例
           

摘要

Colorectal cancer is the third most principal reason of death due to cancer. The applicability of the chemo drug, 5-Fluorouracil (5-FU) is limited due to its non-specificity, low bioavailability and overdose. The efficiency of 5-FU in colorectal cancer therapy could be enhanced by nanoencapsulation and combinatorial approach with Bisdemethoxycurcumin (BDC). In the present work, a new pH sensitive bioactive aminated mesoporous silica-alginate/folic acid conjugated o-carboxymethylchitosan-gelatin (AMSN-Alg/FA-CMCT-Gel) nanocomposite system has been developed to construct for the safe loading of 5-FU and BDC and helps to overcome the limitations of colon cancer. The dual drug delivery system (DDDS) was characterized by means of FTIR, XRD, SEM, TEM, DLS, Zeta potential, and BET adsorption isotherm. The information obtained from the characterization techniques exposed the successful formation of the nanodrug carrier. The 5-FU and BDC loaded DDDS was found to be blood compatible. The in vitro drug release profile in pHs 1.2 and 7.4 showed a sustained release profile over a period of 48 h. The combinatorial approach of 5-FU and BDC in HCT116 cells proved anticancer effects and intracellular uptake of the drug into DDDS was confirmed by Confocal Microscopy.
机译:直肠癌是癌症引起的第三次死亡最初的原因。 ChemOm药物,5-氟尿嘧啶(5-FU)的适用性由于其非特异性,生物利用度和过量而受到限制。通过纳米甲氧基核(BDC)的纳米封装和组合方法可以增强结直肠癌治疗中5-FU的效率。在本作本作中,已经开发出一种新的pH敏感的生物活性胺化介孔二氧化硅 - 藻酸盐/叶酸缀合的O-羧甲基氨基硅烷 - 明胶(AMSN-ALG / FA-CMCT-凝胶)纳米复合材料系统,以防止5-FU和BDC并有助于克服结肠癌的局限性。通过FTIR,XRD,SEM,TEM,DLS,Zeta电位和BET吸附等温线,表征双药物递送系统(DDDS)。从表征技术获得的信息暴露了纳米载体的成功形成。发现5-FU和BDC加载的DDDS符合血液。 pHS 1.2和7.4中的体外药物释放曲线显示在48小时的时间内持续释放曲线。 HCT116细胞5-FU和BDC中的组合方法证明了通过共聚焦显微镜证实了药物进入DDDS的抗癌效果和细胞内摄取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号